IP3 may help liberate calcium ions (Ca) from internal cellular stores
This process helps determine whether BPC-157 therapy is appropriate for your individual needs
Browse all articles, deep dives, and helpful guides in our research library
A meta-analysis covering over 28,000 patients found that while the overall rate of GI adverse events was similar (approximately 5253% of patients in both groups), serious adverse events occurred somewhat more frequently with higher tirzepatide doses (5.37% at 1015 mg) compared to semaglutide (2.8%)
Maximus offers its own lab panels ranging from $199.99 to $349.99, though you can also submit results from your own doctor
Research shows that it may help protect the digestive tract (gi tract), including the gastrointestinal lining, from damage caused by nonsteroidal anti-inflammatory drugs (NSAIDs), helping to maintain gut health and function